+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Horizon Pharma plc - logo

Horizon Pharma plc is a biopharmaceutical company focused on developing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases. The company markets 11 medicines through its orphan, rheumatology and primary care business units, including ACTIMMUNE, BUPHENYL, DUEXIS, RAVICTI, QUINSAIR and PENNSAID. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.

Gout Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gout Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Gout Therapeutics Global Market Report 2024 - Product Thumbnail Image

Gout Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Chronic Back Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Back Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Systemic Sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 500 Pages +
  • Global
From
Biosimilar Growth Hormones Global Market Report 2024 - Product Thumbnail Image

Biosimilar Growth Hormones Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Chronic Pancreatitis Pain - Pipeline Insight, 2020 - Product Thumbnail Image

Chronic Pancreatitis Pain - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Thyroid eye disease - Pipeline Insight, 2024 - Product Thumbnail Image

Thyroid eye disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 194 Pages
  • Global
From
Loading Indicator